New hope for lung cancer patients: phase 3 trial of plinabulin combo launches
Disease control
Not yet recruiting
This study tests whether adding plinabulin to standard chemotherapy (docetaxel) helps people with advanced non-squamous lung cancer live longer. It includes about 442 adults whose cancer has worsened after prior immunotherapy and platinum chemo. Participants are randomly assigned…
Phase: PHASE3 • Sponsor: BeyondSpring Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 08:14 UTC